Association between circulating endothelial progenitor cells and hs-CRP in patients with diabetes

British Journal of Diabetes and Vascular Disease

Volumn 10, Issue 3, 2010, Pages 133-138

  Koshikawa, Megumi ^a   Izawa, Atsushi ^a   Tomita, Takeshi ^a   Kumazaki, Setsuo ^a   Koyama, Jun ^a   Shimodaira, Shigetaka ^a   Ikeda, Uichi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C reactive protein; Diabetes; Endothelial progenitor cell

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CD34 SELECTION; DIABETES MELLITUS; DIABETIC HYPERTENSION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SMOKING; STEM CELL;

EID: 77957158299     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651410365111     Document Type: Article

References (28)

1. Hubacek J, Verma S, Shewchuk L et al. Rationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglit-zone on endothelial function in patients with diabetes. Can J Cardiol 2004;20:1449-53
2. Tepper OM, Galiano RD, Capla JM et al. human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and ncorporation into vascular structures. Circulation 2002;106:2781-6
3. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angio-genesis for patients with critical limb ischemia using autologous bone marrow cell transplantation: a randomized, multicenter, controlled trial. Lancet 2002;360:427-35
4. Tachi Y, Fukui D, Wada Y et al. Changes in angiogenesis-related factors in serum following autologous bone marrow cell implantation for severe limb ischemia. Expert Opin Biol Ther 2008;8:705-12
5. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8
6. Vasa M, Fichtlscherer S, Aicher A et al. number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-7
7. Hill JM, Zalos G, halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600
8. Eizawa T, Ikeda U., Murakami Y et al. Decrease in circulating endotheial progenitor cells in patients with stable coronary artery disease Heart 2004;90:685-6
9. Tepper OM, Galiano RD, Capla JM et al. human endothelial pro-genitor cells from type II diabetic exhibit impaired proliferation, adhe-sion, and incorporation into vascular structures. Circulation 2002; 106:2781-6
10. Ridker PM, hennekens CH, Buring JE et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43
11. Verma S, Wang CH, Li Sh et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 2002;106:913-9
12. Devaraj S, Xu DY, Jiala I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelia cells. Circulation 2003;107:398-04
13. Verma S, Kuliszewski MA, Li Sh et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function Circulation 2004;109:2058-67
14. Hayaishi-okano R, Yamasaki Y, Katakami N et al. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 2002;25:1432-8
15. Eizawa T, Murakami Y, Matsui K et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003;19:627-33
16. Khan SS, Solomon MA, McCoy JP Jr. Detection of circulating endotheial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005;64:1-8
17. Loomans CJ, de Koning EJ, Staal FJ et al. Endothelial progenitor cel dysfunction: a novel concept in the pathogenesis of vascular complica-tions of type 1 diabetes. Diabetes 2004;53:195-9
18. Bahlmann Fh, de Groot K, Mueller o et al. Stimulation of endothelia progenitor cells: A new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005;45:526-9
19. Kusuyama T, Omura T, Nishiya D et al. Effects of treatment for diabetes mellitus on circulating vascular progenitor cells. J Pharmacol Sci 2006;102:96-102 (Pubitemid 44440972)
20. Fadini GP, Sartore S, Albiero M et al. number and function of endothe-ial progenitor cells as a marker of severity for diabetic vasculopathy Arterioscler Thromb Vasc Biol 2006;26:2140-6
21. Fanini GP, Agostini C, Sartore S et al. Significance of endothelial pro-genitor cells in subjects with diabetes. Diabetes Care 2007; 30:1305-13
22. Krankel N, Adams V, Linke A et al. hyperglycemia reduces survival and mpairs function of circulating blood-derived progenitor cells Arterioscler Thromb Vasc Biol 2005;25:698-703
23. Humpert PM, Neuwirth R, Battista MJ et al. SDF-1 genotype influences nsulin-dependent mobilization of adult progenitor cells in type 2 dia-betes. Diabetes Care 2005;28:934-6
24. Brownlee M. The pathobiology of diabetic complications: a unified mechanism. Diabetes 2005;54:1615-25
25. Sorrentino SA, Bahlmann FH, Besler C et al. oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus. Circulation 2007;116:163-73
26. Fujii H, Li S, Szmitko P et al C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells Arterioscler. Thromb Vasc Biol 2006; 26: 2476-82.
27. Suh W, Kim KL, Choi JH et al. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun 2004;321:65-71 (Pubitemid 39055606)
28. Schillinger M, Exner M, Amighi J et al. Joint effects of C-reactive pro-tein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 2003; 108:2323-8